S07-1066

N/A

Report date: 2023/07/07 09:52:52
NME

Base Information

Drug NameS07-1066
Drug Alias NameS07-1066
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAldo-keto-reductase family 1 member C3 inhibitors
TargetsAldo-keto-reductase family 1 member C3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChina Pharmaceutical UniversityGuizhou Medical UniversityChinese Academy Of Sciences +[4] 
China Registration ClassN/A

Develop Information

Active CompaniesChinese Academy Of SciencesNanjing Medical UniversityGuizhou Medical University +[4] 
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A